{
    "clinical_study": {
        "@rank": "99104", 
        "arm_group": [
            {
                "arm_group_label": "tPA alone", 
                "arm_group_type": "Active Comparator", 
                "description": "tPA alone used to treat empyema"
            }, 
            {
                "arm_group_label": "tPA plus dornase", 
                "arm_group_type": "Experimental", 
                "description": "tPA plus dornase used to treat empyema"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to scientifically evaluate a new substrate for fibrinolysis\n      compared to our standard tPA.\n\n      The hypothesis, driven by a recent prospective trial, is that tPA may benefit from the\n      addition of DNAse.\n\n      The primary outcome variable between the two techniques will be length of hospitalization\n      after initiation of treatment."
        }, 
        "brief_title": "Empyema Treated With tPA & DNAse", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Empyema", 
        "condition_browse": {
            "mesh_term": "Empyema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients less than 18 years of age requiring an intervention for empyema by one of the\n        following:\n\n          -  Septation or loculation seen on ultrasound or computed tomography or\n\n          -  Greater than 10,000 white blood cells identified on pleural tap\n\n        Exclusion Criteria:\n\n          -  Immunodeficiency process\n\n          -  Secondary diagnosis or condition that will keep them in the hospital beyond the\n             empyema\n\n          -  Existing contraindications to chest tube\n\n          -  Documented allergy to one of the study medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862458", 
            "org_study_id": "12120552", 
            "secondary_id": "12120552"
        }, 
        "intervention": [
            {
                "arm_group_label": "tPA alone", 
                "intervention_name": "tPA alone", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "tPA plus dornase", 
                "intervention_name": "tPA plus dornase", 
                "intervention_type": "Biological"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tissue Plasminogen Activator"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "empyema", 
            "tPA", 
            "dornase"
        ], 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "contact": {
                "email": "sspeter@cmh.edu", 
                "last_name": "Shawn D St. Peter, MD", 
                "phone": "816-983-6465"
            }, 
            "contact_backup": {
                "email": "swsharp@cmh.edu", 
                "last_name": "Susan W Sharp, PhD", 
                "phone": "816-983-6670"
            }, 
            "facility": {
                "address": {
                    "city": "Kansas City", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "64108"
                }, 
                "name": "Children's Mercy Hospital"
            }, 
            "investigator": {
                "last_name": "Shawn D St. Peter, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Trial: Fibrinolysis With tPA (Tissue Plasminogen Activator) Versus tPA and DNAse in Children With Empyema", 
        "overall_contact": {
            "email": "sspeter@cmh.edu", 
            "last_name": "Shawn D St. Peter, MD", 
            "phone": "816-983-6465"
        }, 
        "overall_contact_backup": {
            "email": "swsharp@cmh.edu", 
            "last_name": "Susan W Sharp, PhD", 
            "phone": "816-983-6670"
        }, 
        "overall_official": {
            "affiliation": "Children's Mercy Hospital and Clinics", 
            "last_name": "Shawn D St. Peter, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Length of stay", 
            "safety_issue": "No", 
            "time_frame": "3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862458"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Children's Mercy Hospital Kansas City", 
            "investigator_full_name": "Shawn St. Peter", 
            "investigator_title": "Assoc Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Children's Mercy Hospital Kansas City", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Mercy Hospital Kansas City", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}